Literature DB >> 10219787

Cognitive deficits in spinocerebellar ataxia 2.

K Bürk1, C Globas, S Bösch, S Gräber, M Abele, A Brice, J Dichgans, I Daum, T Klockgether.   

Abstract

This is one of the first studies assessing the pattern of cognitive impairment in spinocerebellar ataxia 2 (SCA2). Cognitive function was studied in 17 patients with genetically confirmed SCA2 and 15 age- and IQ- matched controls using a neuropsychological test battery comprising tests for IQ, attention, verbal and visuospatial memory, as well as executive functions. Twenty-five percent of the SCA2 subjects showed evidence of dementia. Even in non-demented SCA2 subjects, there was evidence of verbal memory and executive dysfunction. Tests of visuospatial memory and attention were not significantly impaired in the non-demented group compared with controls. There was no relationship between test performance and motor disability, repeat length or age of onset, while disease duration was shown to be inversely correlated with two tests reflecting the progression of cognitive deficits during the course of the disease. Intellectual impairment should therefore not be interpreted as a secondary effect of progressive motor disability, but represents an important and independent part of the SCA2 phenotype.

Entities:  

Mesh:

Year:  1999        PMID: 10219787     DOI: 10.1093/brain/122.4.769

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  32 in total

1.  Reduced phonological similarity effects in patients with damage to the cerebellum.

Authors:  Timothy Justus; Susan M Ravizza; Julie A Fiez; Richard B Ivry
Journal:  Brain Lang       Date:  2005-11       Impact factor: 2.381

2.  Cognitive impairments in patients with spinocerebellar ataxia types 1, 2 and 3 are positively correlated to the clinical severity of ataxia symptoms.

Authors:  Jianhua Ma; Chuanjia Wu; Jing Lei; Xiaoning Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Dissociation between motor and cognitive impairments in SCA2: Evidence from a follow-up study.

Authors:  F Le Pira; S Giuffrida; T Maci; L Marturano; R Tarantello; G Zappalà; A Nicoletti; M Zappia
Journal:  J Neurol       Date:  2007-08-13       Impact factor: 4.849

4.  Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation.

Authors:  A Herman-Bert; G Stevanin; J C Netter; O Rascol; D Brassat; P Calvas; A Camuzat; Q Yuan; M Schalling; A Dürr; A Brice
Journal:  Am J Hum Genet       Date:  2000-05-11       Impact factor: 11.025

5.  Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2.

Authors:  Roberto Fancellu; Dominga Paridi; Chiara Tomasello; Marta Panzeri; Anna Castaldo; Silvia Genitrini; Paola Soliveri; Floriano Girotti
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

Review 6.  Essential Tremor Within the Broader Context of Other Forms of Cerebellar Degeneration.

Authors:  Elan D Louis; Phyllis L Faust
Journal:  Cerebellum       Date:  2020-12       Impact factor: 3.847

7.  Psychotic-affective symptoms and multiple system atrophy expand phenotypes of spinocerebellar ataxia type 2.

Authors:  Kai-Hsiang Chen; Chin-Hsien Lin; Ruey-Meei Wu
Journal:  BMJ Case Rep       Date:  2012-03-20

Review 8.  Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.

Authors:  Arun Kumar Verma; Eshan Khan; Sonali R Bhagwat; Amit Kumar
Journal:  Mol Neurobiol       Date:  2019-08-09       Impact factor: 5.590

9.  Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.

Authors:  Ina Klinke; Martina Minnerop; Tanja Schmitz-Hübsch; Marc Hendriks; Thomas Klockgether; Ullrich Wüllner; Christoph Helmstaedter
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

10.  Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6 : a voxel-based FDG-positron emission tomography analysis.

Authors:  Po-Shan Wang; Ren-Shyan Liu; Bang-Hung Yang; Bing-Wen Soong
Journal:  J Neurol       Date:  2007-04-30       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.